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Background: Most of infertile women with normal follicle stimulating hormone (FSH) levels and antral follicle
count (AFC) at day 2–3 of the period, but poor IVF outcomes may occur when use of routine controlled ovarian
stimulation. This paper is to evaluate the predictive value of age-specific FSH levels for IVF-ET outcomes in women
with normal ovarian function.
Methods: A total of 1287 women undergoing their first IVF cycles were enrolled in this retrospective study. The
FSH levels and AFC of all of the women were within normal ranges (FSH ≤ 12 IU/L;AFC ≥ 5). The patients were
grouped by age (younger: < 33 years, medium-aged:33–37years and older:38–41years), and within each age group,
the patients were subdivided by the upper limit of the 95 % confidence interval (CI) for mean FSH levels. Patients with
FSH levels equal to or greater than the upper 95 % CI of FSH in each age group were included into a premature ovarian
aging (POA) subgroup (younger:FSH≥ 7.84, medium-aged: ≥8.12 and older: FSH≥ 8.47),the remaining patients in each
age group were included into a control subgroup. The outcomes of IVF-ET were compared between the POA subgroup
and the control subgroup in each age group.
Results: In each age group, the total dose of gonadotropin(Gn) in the POA subgroups were significantly higher
than those of the corresponding control subgroups. In the younger and medium-aged groups, women in the
POA subgroups had significantly lower oocyte yields, frozen embryos, and higher rates of poor ovarian
response(POR) than those in the corresponding control subgroups. When controlling for age, BMI and AFC, the
multiple logistic regression analysis indicated the following: In each age group, the total dose of Gn was
significantly correlated with POA; the oocyte yield was significantly related to POA only in the younger group;
and in the whole age groups, the incidence of POR in the POA group was 2.719 times greater than in the control
group (OR = 2.719, 95 % CI [1.598–4.625], P < 0.001).
Conclusion: Basal FSH levels combined with age (age-specific FSH levels) can be used as a more accurate
marker for the ovarian response in women with normal ovarian reserves undergoing IVF-ET, particularly in
women ≤37 years old.
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Because ovarian reserve is the key target of infertility
treatment, its accurate evaluation is extremely important
for predicting the outcomes of in-vitro fertilization
(IVF). However, the diagnostic parameters of diminished
ovarian reserve (DOR) remain controversial [1–3], it has
been widely accepted that DOR can be determined when
the serum basal follicle- stimulating hormone(FSH) con-
centration exceeds the normal range of > 10–12 IU/L [4–6].
DOR is a process that progresses with aging, revealing
the variation in ovary function over time. The transition
period from normal to completely degenerated ovarian
reserve is called early ovarian aging, and during this
period, women are asymptomatic [7, 8],However, for
young women with early ovarian aging, the FSH levels
and antral follicle count (AFC) at day2–3 of the period
are both within normal ranges. Therefore, the use of
routine controlled ovarian stimulation might lead to ad-
verse outcomes, such as a low numbers of retrieved oo-
cytes, high cycle cancellation rates, and low pregnancy
rates. This phenomenon commonly occurs in women
with unknown causes of infertility, and the incidence is
approximately 9 % [9]. Even in young women with a
normal basal FSH level (FSH < 10 IU/L), the number of
retrieved oocytes is significantly different between
women with very high and very low FSH levels [10].
However, why might poor ovarian response (POR)
occur in IVF-assisted pregnant women even when FSH
and AFC are both within normal ranges? This question
is worth deeper investigation. A retrospective study in-
vestigating the clinical outcomes of women with normal
ovarian function (FSH ≤ 12 IU/L) after controlled ovula-
tion stimulation introduced the concept of POA. In the
assessment of ovarian function using FSH, attention
should be paid not only to FSH but also to the woman’s
specific age. In other words, ovarian reserve can be more
accurately determined by the combination of FSH and
age. For relatively young women (e.g., <33 years old), if
FSH is at the upper limit (6.98–12 IU/L) of the normal
range, indicating the age specificity of FSH, DOR might
already be present. Thus, POA is defined as DOR occur-
ring when serum FSH exceeds the upper limit of the
95 % CI of the mean FSH level in each age group. It was
further confirmed that women with POA, even those
with normal bFSH, might have fewer eggs or available
embryos [11]. Other researchers also think that only the
combination of FSH and specific age can more accur-
ately determine ovarian reserve. In IVF-assisted pregnant
women, bFSH ≤ 10 IU/L combined with specific age
could better predict the number of retrieved oocytes
[12]. Antral follicle count(AFC) is also an index predict-
ing the ovarian response to controlled ovulation stimula-
tion [13, 14]. At AFC ≤ 5, poor ovarian response to
ovulation stimulation will easily occur [13, 15]. Thus, weshould consider the joint effects of age-specific FSH and
AFC on POA.
The objective of this study was to evaluate the predict-
ive value of age-specific FSH levels for IVF-ET outcomes
in women with normal ovarian function.
Methods
Study population and design
The study was conducted after receiving Ethical
Committee of the Sun Yat-sen Memorial Hospital ap-
proval. The patients were provided with counseling, and
signed consent forms were obtained.
We retrospectively analyzed 1,287 women who under-
went their first cycle of IVF treatment in the
Reproduction Center at Sun Yat-sen Memorial Hospital,
Sun Yat-sen University, between January 2008 and
December 2011. The POA patients were screened, and
their FSH levels were analyzed. The inclusion criteria
were as follows: normal ovarian function; FSH ≤ 12 IU/L
and AFC ≥ 5 at days 2–5 during the period; age ≤
41 years; and an IVF treatment regimen using a standard
luteal-phase long protocol. The exclusion criteria were
as follows: complicating uterine abnormalities, such as
hysteromyoma and adenomyosis; polycystic ovary syn-
drome, thyroid disease, adrenal disease, hyperprolactine-
mia or other endocrine disease; and congenital genital
tract malformation, pelvic tuberculosis, or ovarian tumor.
The diagnosis of POA
The patients were divided by age into three groups:
younger (<33 years old), medium-aged (33–37 years
old), and older (38–41 years old) groups. The 95 % con-
fidence interval (CI) of the FSH level was computed for
each group. Based on the Barad et al. POA classification
method, patients whose FSH levels exceeded the upper
limit of the 95 % CI of the mean for each age group were
included in a POA subgroup [11], According to studies
of the prediction of ovary reaction using AFC [13, 15],
we included patients with FSH ≤12 IU/L, AFC ≥ 5, and
FSH levels equal to and greater than the upper limit of
the 95 % CI of the mean into the POA subgroup in each
age group, whereas those with FSH levels less than the
upper limit of the 95 % CI of the mean were placed into
a control subgroup.
Ovarian stimulation, insemination, and IVF treatment
Controlled ovulation stimulation was undertaken as fol-
lows. During the mid-luteal phase of the previous cycle
before starting, gonadotropin releasing hormone agonist
(GnRH-a, Ipsen Pharma Biotech, France) was injected
for pituitary down-regulation; 10–14 days later, at day
3–5 of the period, hormone levels were detected after pituit-
ary down-regulation. Combined with the patient’s age and
AFC, we provided recombinant follicle-stimulating hormone
Table 1 FSH levels for the POA and control groups
Age(years) FSH levels (IU/L)
Mean(95%CI)a POA Control
<33 7.71 (7.58–7.84) ≥7.84 <7.84
33 ~ 37 7.97 (7.82–8.12) ≥8.12 <8.12
38 ~ 41 8.14 (7.81–8.47) ≥8.47 <8.47
aThe data are presented as mean[95 % confidence interval (CI)] for FSH levels
T2 T3
T4
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(Gonal-F, Merck Serono, Geneva, Switzerland) was150–
300 IU/day depending on patient’s AFC, during ovulation
stimulation, blood E2, progestogen and LH were detected.
The dose of gonadotropin(Gn) was adjusted depending on
the patient’s ovarian response. Follicular development was
monitored via vaginal ultrasound. If bilateral ovaries con-
tained 3 or more follicles ≥16 mm in diameter, 2 or more
follicles ≥17 mm in diameter, or 1 or more follicles ≥18 mm
in diameter, and serum E2 was greater than the expected
level consistent with the size and the number of follicles,
then human chorionic gonadotropin (HCG, Livzon, Zhuhai,
China or Ovidrel, Serono) was injected that night. Approxi-
mately 34–36 h later, eggs were collected. After 3–4 h,
fertilization was conducted via routine IVF. The outcome
was observed after 18 h. After further cultivation to 72 h, 2–
3 high-quality embryos were transferred. The remaining
available embryos were freeze-stored. The transferred em-
bryos were supported via routine injection of progesterone.
At 14 days after transfer, serum hCG was detected. The
hCG-positive patients were preliminarily diagnosed with
biochemical pregnancy. At day 30, the patients received
ultrasonic examinations. Those with a gestational sac and
embryo bud or cardiovascular pulsation in the womb were
diagnosed with clinical pregnancy.
Hormonal measurements
(1)Blood sampling: At days 1–5 of the cycle, basic sex
hormone levels, including FSH, LH, E2, testosterone
and prolactin, were measured.
(2)Processing method: After complete natural
solidification, blood in vacuum sampling tubes was
centrifuged at room temperature and 3000 rpm for
10 min, and an appropriate amount of serum was
removed and sent for further analysis.
(3)Reagents and methods: Supporting reagents and
devices (Beckman coulter, USA) were used in the
automatic detection, plotting of standard curves, and
analysis.
Sample size calculation









According to the formula for two-group divisible de-
sign sample size estimation and using the number of oo-
cytes retrieved as the primary outcome measurement,
with an accuracy index α = 0.05 and power = 80 % in a
bilateral variability test, if POA and non-POA patients in
each age group were matched 1:1 in this study, the total
sample size would be 344 in the younger group (POAgroup = 172 subjects, control group =172 subjects), 360
in the medium-aged group (POA group = 180 subjects,
control group = 180 subjects), and 290 in the older
group (POA group = 145 subjects, control group = 145
subjects). Thus, our sample size achieved this require-
ment with 650 in the younger group (POA group = 294
subjects, control group = 356 subjects) and 539 in the
medium-aged group (POA group = 228 subjects, control
group = 311 subjects), but the small sample size of the
older group (POA group = 39 subjects, control group = 59
subjects) did not meet this requirement.Statistical analysis
Statistical analysis was performed using SPSS software
(version 20.0, IBM Corporation, USA). Data with normal
distributions and continuous variables are expressed as
mean ± standard deviation; data without normal distribu-
tions are expressed as medians (interquartile ranges). Data
with normal distributions were compared between groups
via the t-test, while data without normal distribution were
compared via the Mann–Whitney U test. Qualitative data
were compared between groups by the chi-square (χ2) test.
A multiple logistic regression analysis was conducted to
evaluate the correlation between POA and IVF outcomes
when controlling for the confounders of age, BMI, and
AFC. The test level was set at α = 0.05. Statistical signifi-
cance was set at P < 0.05.Results
Baseline characteristics of the patients who were enrolled
in the study (Tables 2, 3 and 4)
In total, 1,287 patients were included in this study. The
average age was 32.08 ± 4.02 years. The average FSH was
7.85 ± 1.74 IU/L. The average BMI was 21.28 ± 2.89 kg/m2.
The average AFC was 14.56 ± 5.84. The patients were
divided by age into three groups: a younger group
(<33 years old, 50.50 %, 650/1,287), a medium-aged
group (33–37 years old, 41.88 %, 539/1,287), and an
older group (38–41 years old, 7.61 %, 98/1,287).POA diagnosis
The diagnosis of POA, as shown in Table 1, was accom-
plished using FSH levels for the POA and control groups
of ≥7.84 IU/L vs. < 7.84 IU/L (younger group), ≥8.12 IU/L
Table 2 Baseline characteristics and IVF outcomes in the POA and control groups in women aged <33 years
Characteristics <33 years old t/z(χ2) P
Control POA
n 356 294
Age(y)a 28.64 ± 2.49 28.92 ± 2.37 1.462 0.144
Infertility years(y)a 3.84 ± 2.48 3.81 ± 2.34 −0.140 0.889
BMI(kg/m2)a 21.30 ± 3.06 20.35 ± 2.27 −4.528 <0.001
FSH(IU/L)a 6.46 ± 1.03 9.21 ± 1.00 34.362 <0.001
LH(IU/L)b 3.81(2.94–4.89) 4. 78(3.62–5.82) 44.850 <0.001
E2(ng/L)
b 38.00(25.90–51.00) 37.77(26.00–50.58) 0.039 0.844
FSH/LHb 1.76(1.32–2.18) 1.95(1.57–2.50) 20.869 <0.001
AFC(n)a 16.14 ± 5.82 14.58 ± 5.25 −3.554 <0.001
Total dose of Gn (IU)a 1,874.20 ± 609.07 2,051.08 ± 612.17 3.639 <0.001
E2 level on DHCG (ng/L)
b 3,818.70 (2,413.24–4,800.00) 3,563.50 (2,222.75–4,800.00) 3.107 0.078
Number of retrieved oocytes(n)a 14.86 ± 7.35 12.55 ± 6.22 −4.234 <0.001
Rate of POR(%)c 1.42(5/353) 6.46(19/294) 11.585 0.001d
Number of frozen embryos (n)b 5.00(3.00–8.00) 5.00(3.00–8.00) 3.895 0.048
Number of available embryos (n)b 7.00(5.00–10.00) 7.00(4.00–9.00) 3.761 0.052
Fertilization rate(%)c 84.62(66.67–94.44) 85.71(71.43–100.00) 1.858 0.173
Cleavage rate(%)c 100.00 (100.00–100.00) 100.00 (100.00–100.00) 0.221 0.638
Cancellation rate(%)c 0.84(3/356) 2.72(8/294) 3.415 0.065e
Pregnancy rate (%)c 55.52(196/353) 54.55(156/286) 0.061 0.805
aThe normally distributed data are presented as the mean ± SD, including age, infertility years, BMI, FSH, AFC, total dose of Gn, and number of retrieved oocytes.
The t-test was performed to analyze statistical significance
bThe non-normally distributed data are presented as the median (25–75th percentile). The non-parametric Mann–Whitney test was performed to calculate
the Z-score
cThe chi-square (χ2) test was performed to analyze statistical significance
dThe rate of POR = (the cycles of oocyte yields ≤ 3 + the cycles cancelled egg retrieval)/the total cycles
eThe cancellation rate only included the cycles of cancelled egg retrieval
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vs. < 8.47 IU/L (older group), respectively.
The correlation between POA and IVF outcomes
Tables 2, 3 and 4 show that the incidence rates of POA
were 45.23 % (294/650), 42.30 % (228/539), and 39.80 %
(39/98) in the younger, medium-aged and older groups,
respectively. In the POA subgroups of the younger and
medium-aged groups, although FSH, FSH/LH and AFC
were all normal, the number of retrieved oocytes in both
POA subgroups were significantly smaller, compared to
the corresponding control subgroups (12.55 ± 6.22
vs.14.86 ± 7.35, P < 0.05, younger group; 11.06 ± 5.79 vs.
12.81 ± 6.88, P < 0.05, medium-aged group). The total dose
of Gn in the two POA subgroups were significantly higher
than in the corresponding control subgroups (2,051.08 ±
612.17vs. 1,874.20 ± 609.07, P < 0.05, younger group;
2,470. 68 ± 812.84 vs. 2,121.75 ± 766.98, P < 0.05, medium-
aged group). The incidence rates of poor ovarian response
(POR) in the two POA subgroups were both significantly
higher (6.46 % vs.1.42 %, younger group; 8.77%vs.4.50 %,
medium-aged group). The incidence rates of pregnancy inthe POA subgroups were not significantly different, com-
pared with the corresponding control subgroups. How-
ever, the number of frozen embryos was significantly
smaller in the POA subgroups (P < 0.05). Therefore, the
difference in incidence rates of pregnancy might be mani-
fested as the outcomes for cumulative pregnancy. The
fertilization rates, the cleavage rates and the numbers of
available embryos were not significantly different between
the subgroups. In the medium-aged group, the E2 levels
on DHCG in the POA subgroup were significantly lower
than in the control subgroup (2,804.00[1,844.50–4,765.25]
vs. 3,505.00[2,276.75–4,800.00], P < 0.05). In the older
group, the total dose of Gn was significantly higher in the
POA subgroup than in the control subgroup (3,388.92 ±
1,638.73vs. 2,633.63 ± 1,000.45, P = 0.007); there were no
significant differences in the number of retrieved oocytes,
rate of POR, E2 level on DHCG day, number of frozen em-
bryos, fertilization rate, and pregnancy rate between the
two subgroups.
The results of the multiple logistic regression analysis
are shown in Table 5 and indicate that in all age groups,
after controlling for the confounders of age, BMI and
Table 3 Baseline characteristics and IVF outcomes in the POA and control groups in women aged 33–37 years
Characteristics 33 ~ 37 years old t/z(χ2) P
Control POA
n 311 228
Age(y)a 34.82 ± 1.25 34.86 ± 1.32 −0.327 0.744
Infertility years(y)a 5.67 ± 3.65 5.43 ± 3.54 0.736 0.462
BMI(kg/m2)a 21.89 ± 2.98 21.29 ± 2.98 2.336 0.020
FSH(IU/L)a 6.74 ± 1.10 9.64 ± 1.05 −30.747 <0.001
LH(IU/L)b 3.67(2.69–4.84) 4. 47 (3.36–5.69) 26.754 <0.001
E2(ng/L)
b 36.00(25.00–50.48) 37.77(24.00–51.74) 1.036 0.309
FSH/LHb 1.87(1.41–2.51) 2.18(1.66–2.88) 20.070 <0.001
AFC(n)a 15.14 ± 6.30 12.98 ± 5.29 4.313 <0.001
Total dose of Gn (IU)a 2,121.75 ± 766.98 2,470. 68 ± 812.84 −5.087 <0.001
E2 level on DHCG (ng/L)
b 3,505.00 (2,276.75–4,800.00) 2,804.00 (1,844.50–4,765.25) 7.670 0.006
Number of retrieved oocytes(n)a 12.81 ± 6.88 11.06 ± 5.79 3.080 0.002
Rate of POR(%)c 4.50(14/311) 8.77(20/228) 4.059 0.044d
Number of frozen embryos (n)b 4.00(1.00–7.00) 3.00(1.00–6.00) 3.978 0.046
Number of available embryos (n)b 6.00(3.00–8.00) 5.00(3.00–8.00) 2.920 0.088
Fertilization rate (%)c 83.33(71.43–92.31) 85.71(70.80–100.00) 2.132 0.144
Cleavage rate (%)c 100.00 (100.00–100.00) 100.00 (100.00–100.00) 0.177 0.674
Cancellation rate(%)c 0. 96(3/311) 2.60(6/228) 2.226 0.136e
Pregnancy rate(%)c 46.43(143/308) 42.79 (95/222) 0.689 0.406
a The normally distributed data are presented as the mean ± SD, including age, infertility years, BMI, FSH, AFC, total dose of Gn, and number of retrieved oocytes.
The t-test was performed to analyze statistical significance
bThe non-normally distributed data are presented as the median (25–75th percentile). The non-parametric Mann–Whitney test was performed to calculate
the Z-score
cThe chi-square (χ2) test was performed to analyze statistical significance
dThe rate of POR = (the cycles of oocyte yields ≤ 3 + the cycles cancelled egg retrieval)/the total cycles
eThe cancellation rate only included the cycles of cancelled egg retrieval
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with POA (OR = 1.328, 95 % CI [1.140–1.546], P <
0.001,younger group; OR = 1.535,95 % CI [1.285–1.834],
P < 0.001,medium-aged group; OR = 1.939,95 % CI
[1.212–3.102], P = 0.006,old group;). However, the num-
ber of retrieved oocytes was significantly correlated with
POA only in the younger group (OR = 0.958, 95 % CI
[0.933–0.984], P = 0.002).
The correlation between POA and POR
The multiple logistic regression analysis of the correl-
ation between POA and POR in the whole age groups
after controlling for the confounders of age, BMI and
AFC, as shown in Table 6, revealed that the incidence of
POR in the POA subgroup was 2.719 times greater than
in the control subgroup (OR = 2.719, 95 % CI [1.598–
4.625], P < 0.001).
Discussion
Ovarian reserve can be assessed by many indicators, in-
cluding serum FSH, estradiol, inhibin B, anti-Müllerian
hormone (AMH), and AFC. The objective with eachindicator is to predict the response to ovulation stimula-
tion and the success rate of pregnancy. “FSH level on
day 2–3 of the period” is a widely used indicator of ovar-
ian reserve. It is generally accepted that FSH level can
effectively predict the ovarian response to ovulation
stimulation. As reported, FSH is more effective than age
in predicting the IVF/ICSI ovarian response and cycle
cancellation rate, whereas age is more effective in pre-
dicting the IVF pregnancy rate [17]. A 1045-case retro-
spective study showed that age and basal FSH could
both effectively predict the number of retrieved oocytes,
but age could more effectively predict the IVF pregnancy
rate [18]. A meta-analysis indicated that FSH level was a
key indicator of the outcome of IVF [19]. A prospective
study compared basal AFC, AMH, ovarian volume, and
FSH in predicting the ovarian response to ovulation
stimulation, and the findings indicated that basal FSH
and AFC were sensitive biomarkers for predicting ovar-
ian response [20].
The incidence of early ovarian aging is 10 %; specific-
ally, the incidence of premature ovarian failure is ~1 %,
and the remaining women (~9 %) have a slight to
Table 4 Baseline characteristics and IVF outcome in POA and control groups in women with age 38–41 years old
38 ~ 41 years old t/z(χ2) p
Control POA
n 59 39
Age (y)a 39.07 ± 1.10 38.95 ± 1.05 −0.535 0.594
Infertility years(y)a 6.95 ± 5.21 6.59 ± 4.08 −0.387 0.700
BMI (kg/m2)a 22.36 ± 3.28 21.62 ± 1.64 −1.481 0.142
FSH(IU/L)a 7.05 ± 0.97 9.79 ± 0.87 14.27 <0.001
LH(IU/L)b 3.39(2.48–4.23) 3.63(3.01–4.53) −1.513 0.13
E2 (ng/L)
b 35.95(29.60–49.80) 39.71(31.38–53.97) −0.947 0.344
FSH/LHb 2.12(1.63–2.84) 2.84(2.13–3.20) 10.175 0.001
AFC(n)a 11.17 ± 5.09 9.58 ± 3.33 −1.705 0.092
Total dose of Gn (IU)a 2,633.63 ± 1000.45 3,388.92 ± 1638.73 2.778 0.007
E2 level on DHCG (ng/L)
b 2,474.20 (1,789.25–3,954.14) 2,437.00 (1,272.67–3,719.84) 0.685 0.494
Number of retrieved oocytes (n)a 10.26 ± 5.75 8.36 ± 4.36 −1.698 0.093
The rate of POR (%)c 5.08(3/59) 20.51(8/39) 5.609 0.018d
Number of frozen embryos (n)b 2.00(0.00–4.00) 2.00(0.00–4.00) −0.470 0.638
Number of available embryos (n)b 4.50(3.00–7.00) 5.00(3.00–7.00) −0.129 0.898
Fertilization rate (%)c 79.29(58.33–96.25) 89.44(64.39–100.00) −1.587 0.113
Cleave rage rate (%)c 98.75 (100.00–100.00) 100.00 (100.00–100.0) −1.941 0.052
Cancellation rate (%)c 1.70(1/59) 7.69(3/39) 2.157 0.142e
Pregnancy rate (%)c 25.86(15/58) 34.29(12/36) 0.606 0.436
aThe normally distributed data are presented as the mean ± SD, including age, infertility years, BMI, FSH, AFC, total dose of Gn, and number of retrieved oocytes.
The t-test was performed to analyze statistical significance
bThe non-normally distributed data are presented as the median (25–75th percentile). The non-parametric Mann–Whitney test was performed to calculate
the Z-score
cThe chi-square (χ2) test was performed to analyze statistical significance
dThe rate of POR = (the cycles of oocyte yields ≤ 3 + the cycles cancelled egg retrieval)/the total cycles
eThe cancellation rate only included the cycles of cancelled egg retrieval
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concept of POA was proposed and defined as an FSH
level higher than the 95 % CI in the specific age group,
combined with the occurrence of DOR. POA could ac-
count for the “unknown cause” of infertility in some in-
fertile women. Currently, most studies have concluded
that AFC is closely correlated with ovarian response.
Based on the concept of POA and using the value of
AFC for predicting ovarian reserve, we defined POA as
FSH ≤ 12 IU/L, AFC ≥ 5, and FSH level higher than theTable 5 The multiple logistic regression for the relationship betwee
<33 years 33 ~
B P OR (95 % CI) B
Age 0.048 0.181 1.049(0.978–1.125) −0.0
BMI −0.185 0.000 0.831(0.776–0.891) −0.0
AFC −0.019 0.268 0.981(0.949–1.015) −0.0
Number of retrieved oocytes −0.043 0.002 0.958(0.933–0.984) −0.0
Total dose of Gna 0.283 <0.001 1.328(1.140–1.546) 0.42
aGn are transformed into ordinal variable according to the median (25–75th percen95 % CI in the specific age group. Our results were con-
sistent with the study by Barad DH et al., which showed
that patients with POA, even with normal ovarian func-
tion, had significantly fewer retrieved oocytes than the
non-POA patients in each age group.
Further experiments showed that the total dose of Gn
in the POA subgroup was significantly larger than in the
control subgroup at a specific age. Among the patients
with POA, the incidence of POR was 6.46 % in the
younger group, 8.77 % in the medium-age group. In then POA and main IVF outcomes in each age group
37 years 38 ~ 41 years
P OR (95 % CI) B P OR (5 % CI)
69 0.348 0.933(0.807–1.079) −0.375 0.114 0.687(0.431–1.095)
90 0.006 0.914(0.857–0.975) −0.125 0.193 0.882(0.730–1.065)
32 0.086 0.969(0.934–1.004) −0.050 0.384 0.951(0.850–1.064)
15 0.348 0.985(0.954–1.017) −0.036 0.489 0.965(0.872–1.068)
8 <0.001 1.535(1.285–1.834) 0.662 0.006 1.939(1.212–3.102)
tile)
Table 6 The multiple logistic regression for low ovarian
response versus POA
B S.E. Wald P OR 95 % CI
Age 0.088 0.035 6.300 0.012 1.092(1.019–1.170)
BMI −0.005 0.046 0.011 0.917 0.995(0.910–1.089)
AFC −0.073 0.028 6.833 0.009 0.929(0.879–0.982)
POA 1.002 0.271 13.603 0.000 2.719(1.598–4.625)
Concept −5.244 1.556 11.357
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cantly less in the POA subgroup than in the control sub-
group. The number of frozen embryos in the POA
subgroup was significantly smaller than in the control
subgroup of younger and medium-age groups. The
fertilization rates, the cleavage rates were, the number of
available embryos and the pregnancy rates were not sig-
nificantly different between the subgroups.
Our results demonstrated that the numbers of re-
trieved oocytes, the total doses of Gn, and the POR rates
all differed between the patients with and without POA.
Even after controlling for the confounders of age, BMI
and AFC, the total Gn dose was also significantly corre-
lated with POA in each age group, and the oocyte yield
was significantly correlated with POA in the younger
group. We deduced that the reduction of early ovarian
reserve, a decreased number of follicle pools, and induc-
tion of more severe Gn resistance likely resulted in to
low ovarian response to follicle stimulation, consistent
with previous studies [21, 22]. The fertilization rates and
the cleavage rates were both not significantly different
between the patients with and without POA in each age
group, indicating that FSH could not predict the quality
of eggs, consistent with previous studies [22, 23]. More-
over, the number of available embryos and the preg-
nancy rates decreased among patients with POA. Thus,
we deduced that the early elevation of FSH might reduce
the number of available embryos, in turn resulting in a
reduced number of ET embryos, thereby reducing the
clinical pregnancy rate. In the younger and medium-age
groups, the number of frozen embryos was significantly
less in patients with POA than in the non-POA group;
thus, the difference in incidence rates of pregnancy
might have been manifested as the outcomes of cumula-
tive pregnancy.
Our study indicated again that FSH was effective in
predicting the ovarian response to follicle stimulation.
However, this study was also different from some previ-
ous studies [24, 25]. In our study, we included those in-
fertile women with normal FSH and AFC. However,
because all of the cases exceeded the upper limit of the
age-specific 95 % CI for FSH, the number of retrieved
oocytes and the ovarian response were reduced, leading
to poor outcomes of IVF. Our study showed that, in themedium-age and older groups, the incidence rates of
POR in patients with POA were 8.77 % and 20.51 %, re-
spectively. Thus, if early diagnosis of POA is possible,
more information about ovarian reserve could be ob-
tained prior to IVF, and an individualized ovulation-
stimulating strategy could be promptly undertaken
depending on the ovarian age; with this strategy, an ap-
propriate number of eggs could be obtained, and the
cycle cancellation rate and the incidence rate of POR
could be reduced, all of which would improve the clin-
ical pregnancy rate and the clinical outcomes of IVF.
A limitation of this study was the small sample size of
patients in the older group, which might have resulted
from the smaller number of older women with FSH
levels <12 IU/L; this limitation rendered certain signifi-
cant differences difficult to assess. Another limitation
was the retrospective design. Although in the younger
and medium-aged groups, the sample size met the re-
quirement for a two-group divisible design, a random-
ized prospective study is necessary. AMH is a relatively
new marker for ovarian reserve evaluations that has
been validated in many studies [26–28]. Whether the
age-specific FSH level is consistent with changes in
AMH and whether AMH combined with the age-
specific FSH level might be a new, more accurate marker
for predicting ovarian reserve merit further study.
Conclusion
For women with normal ovarian function who plan to
receive follicle-stimulating in vitro fertilization, particu-
larly those ≤37 years old, basal FSH levels combined
with age (age-specific FSH levels) can be used as a more
accurate marker to evaluate ovarian reserve.
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